Fri Aug 4 16:55:15 2006
Robust hepatitis C virus infection in vitro
Zhong J, Gastaminza P, Cheng GF, et al.
PNAS 102 (26): 9294-9299 JUN 28 2005
and citing papers
stopwords, and 2-character and smaller words are excluded, Word count: 611, All words count: 910
Grand TLCS: 121, Grand TGCS: 212View: Overview | Sorted by word. |
Page 2 of 2: [ 1 2 ]
# | Word | Pubs | TLCS | TGCS
|
---|
201 | NS5B | 1 | 0 | 0
|
202 | NS5B-NUCLEOLIN | 1 | 0 | 0
|
203 | NUMBER | 1 | 0 | 0
|
204 | OCCURS | 1 | 1 | 2
|
205 | OLIGONUCLEOTIDE-BASED | 1 | 0 | 0
|
206 | OPTIONS | 1 | 0 | 0
|
207 | OXIDIZED | 1 | 1 | 1
|
208 | OXLDL | 1 | 0 | 0
|
209 | PARALLEL | 1 | 0 | 0
|
210 | PARTICLES | 2 | 0 | 0
|
211 | PATHWAY | 1 | 7 | 41
|
212 | PEPTIDE | 1 | 0 | 0
|
213 | PESTIVIRUS | 1 | 0 | 1
|
214 | PH-DEPENDENT | 1 | 3 | 3
|
215 | PHANTOM | 1 | 0 | 0
|
216 | POLYMERASE | 2 | 0 | 1
|
217 | POLYPROTEIN | 1 | 0 | 0
|
218 | POTENT | 2 | 0 | 0
|
219 | POTENTIAL | 2 | 0 | 0
|
220 | PRACTICE | 1 | 0 | 1
|
221 | PREVENTION | 1 | 0 | 0
|
222 | PRODUCTION | 4 | 4 | 5
|
223 | PROFILES | 1 | 0 | 0
|
224 | PROMOTER | 1 | 1 | 1
|
225 | PROPERTIES | 1 | 0 | 0
|
226 | PROSPECTS | 1 | 1 | 6
|
227 | PROTEASE | 2 | 0 | 0
|
228 | PROTEASE-DEPENDENT | 1 | 0 | 0
|
229 | PROTEIN | 4 | 7 | 42
|
230 | PROTEINS | 3 | 1 | 1
|
# | Word | Pubs | TLCS | TGCS
|
---|
231 | PSEUDOPARTICLE | 1 | 0 | 0
|
232 | PSEUDOPARTICLES | 1 | 1 | 2
|
233 | QUANTITATIVE | 2 | 2 | 4
|
234 | REARRANGEMENT | 1 | 0 | 0
|
235 | RECENT | 1 | 0 | 1
|
236 | RECEPTOR | 2 | 0 | 0
|
237 | RECEPTORS | 2 | 0 | 0
|
238 | RECOMBINANT | 1 | 1 | 2
|
239 | RECULTURED | 1 | 2 | 2
|
240 | REGIONS | 1 | 0 | 0
|
241 | REPLICATES | 1 | 1 | 1
|
242 | REPLICATION | 10 | 10 | 22
|
243 | REPLICON | 6 | 1 | 1
|
244 | REPLICONS | 1 | 0 | 0
|
245 | REPORTER | 2 | 0 | 0
|
246 | REQUIRES | 2 | 1 | 2
|
247 | RESEARCH | 2 | 0 | 0
|
248 | RESPONSES | 2 | 0 | 0
|
249 | REVEALED | 1 | 1 | 1
|
250 | RIBAVIRIN | 2 | 4 | 16
|
251 | RIG-I | 1 | 7 | 41
|
252 | RIGING | 1 | 0 | 0
|
253 | RNA | 8 | 0 | 2
|
254 | RNA-DEPENDENT | 1 | 0 | 1
|
255 | ROBUST | 2 | 73 | 73
|
256 | ROLE | 1 | 0 | 0
|
257 | SALIENT | 1 | 1 | 1
|
258 | SAR | 1 | 0 | 0
|
259 | SCAVENGER | 2 | 0 | 0
|
260 | SCH | 1 | 0 | 0
|
# | Word | Pubs | TLCS | TGCS
|
---|
261 | SECRETION | 1 | 0 | 0
|
262 | SELECTIVE | 1 | 0 | 1
|
263 | SENSITIVE | 1 | 1 | 1
|
264 | SHORT | 1 | 0 | 0
|
265 | SIGNAL | 1 | 0 | 0
|
266 | SIGNALING | 1 | 0 | 0
|
267 | SIGNALS | 1 | 0 | 0
|
268 | SIMULTANEOUS | 1 | 0 | 0
|
269 | SINUSOIDAL | 1 | 0 | 0
|
270 | SR-BI | 1 | 0 | 0
|
271 | STABLY | 1 | 2 | 2
|
272 | STAGES | 1 | 0 | 0
|
273 | STATINS | 1 | 0 | 0
|
274 | STEPS | 1 | 0 | 0
|
275 | STIMULATING | 1 | 0 | 0
|
276 | STIMULATOR | 1 | 1 | 1
|
277 | STRAIN | 2 | 1 | 1
|
278 | STRATEGIES | 1 | 0 | 0
|
279 | STRUCTURAL | 1 | 1 | 1
|
280 | STRUCTURE | 1 | 0 | 0
|
281 | SUBCELLULAR | 1 | 1 | 1
|
282 | SUBGENOMIC | 3 | 0 | 0
|
283 | SUPPRESSES | 1 | 0 | 0
|
284 | SUSTAINED | 1 | 0 | 1
|
285 | SYSTEM | 3 | 5 | 5
|
286 | TARGET | 1 | 0 | 0
|
287 | TARGETED | 1 | 7 | 41
|
288 | TARGETING | 1 | 0 | 0
|
289 | TARGETS | 2 | 0 | 1
|
290 | TEMPERATURE-DEPENDENT | 1 | 4 | 4
|
# | Word | Pubs | TLCS | TGCS
|
---|
291 | TETRASPANIN | 1 | 0 | 0
|
292 | THERAPEUTIC | 3 | 1 | 1
|
293 | THERAPY | 3 | 0 | 0
|
294 | THIENYL | 1 | 0 | 0
|
295 | THREE-DIMENSIONAL | 1 | 0 | 0
|
296 | TIME-AND | 1 | 4 | 4
|
297 | TISSUE | 2 | 1 | 2
|
298 | TOLL-LIKE | 1 | 0 | 0
|
299 | TRACT | 1 | 0 | 0
|
300 | TRANSIENT-REPLICATION | 1 | 0 | 0
|
301 | TRANSLATION | 1 | 0 | 1
|
302 | TRAP | 1 | 0 | 0
|
303 | TREATMENT | 1 | 3 | 15
|
304 | TRIGGER | 1 | 0 | 0
|
305 | TROJAN | 1 | 0 | 0
|
306 | TWO | 1 | 0 | 0
|
307 | TWO-AND | 1 | 0 | 0
|
308 | UNRAVELLING | 1 | 8 | 15
|
309 | UNSCRAMBLING | 1 | 3 | 9
|
310 | USING | 2 | 0 | 0
|
311 | VACCINE | 1 | 1 | 6
|
312 | VECTORS | 1 | 0 | 0
|
313 | VIABLE | 1 | 0 | 0
|
314 | VIRAL | 5 | 1 | 2
|
315 | VIROLOGIC | 1 | 0 | 1
|
316 | VIROLOGY | 1 | 0 | 0
|
317 | VIRUS | 54 | 115 | 186
|
318 | VIRUS-HOST | 1 | 3 | 9
|
319 | VIRUS-INFECTED | 1 | 0 | 0
|
320 | VIRUS-LIKE | 1 | 0 | 0
|
# | Word | Pubs | TLCS | TGCS
|
---|
321 | VIRUS-NEUTRALIZING | 1 | 0 | 0
|
322 | VIRUSES | 1 | 0 | 0
|
323 | VITRO | 3 | 73 | 73
|
324 | VIVO | 2 | 2 | 2
|
Page 2 of 2: [ 1 2 ]